— Know what they know.
Not Investment Advice

PDSB NASDAQ

PDS Biotechnology Corporation
1W: -6.1% 1M: +253.1% 3M: -11.5% YTD: -10.2% 1Y: -26.6% 3Y: -85.3% 5Y: -95.5%
$0.75
+0.04 (+6.00%)
 
Weekly Expected Move ±48.3%
$0 $0 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 60 · $41.9M mcap · 54M float · 28.57% daily turnover · Short 42% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-34M
Net Income
+8.0% YoY
$-17M
Free Cash Flow
+51.2% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-544.0%
ROA-136.6%
ROIC456.9%

Valuation

P/E-1.2
P/B-11.6
EV/EBITDA-1.8

Leverage

Debt/Equity-1.22
Current Ratio0.57
Interest Cov.-4.1x

Quality Scores

Piotroski F1/9
Altman Z-45.67
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms